Structure-Based Drug Design of ADRA2A Antagonists Derived from Yohimbine
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Artem Chayka und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, Prague 6 160 00, Czech Republic. Hauptthemen laut MEDLINE: Receptors, Adrenergic, alpha-2, Yohimbine, Drug Design, Adrenergic alpha-2 Receptor Antagonists. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ?stav organick? chemie a biochemie Akademie ved Cesk? republiky.
Abstract (Originalsprache)
Yohimbine, a natural indole alkaloid and a nonselective adrenoceptor antagonist, possesses potential benefits in treating inflammatory disorders and sepsis. Nevertheless, its broader clinical use faces challenges due to its low receptor selectivity. A structure-activity relationship study of novel yohimbine analogues identified amino esters of yohimbic acid as potent and selective ADRA2A antagonists. Specifically, amino ester 4n, in comparison to yohimbine, showed a 6-fold higher ADRA1A/ADRA2A selectivity index (SI > 556 for 4n) and a 25-fold higher ADRA2B/ADRA2A selectivity index. Compound 4n also demonstrated high plasma and microsomal stability, moderate-to-low membrane permeability determining its limited ability to cross the blood-brain barrier, and negligible toxicity on nontumor normal human dermal fibroblasts. Compound 4n represents an important complementary pharmacological tool to study the involvement of adrenoceptor subtypes in pathophysiologic conditions such as inflammation and sepsis and a novel candidate for further preclinical development to treat ADRA2A-mediated pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, Prague 6 160 00, Czech Republic.
ORCID-Profile: Břetislav Brož, Zlatko Janeba
Förderung
- ?stav organick? chemie a biochemie Akademie ved Cesk? republiky
Zitieren
APA
Chayka, A., Česnek, M., Kužmová, E., Kozák, J., Tloušt'ová, E., Dvořáková, A., Strmeň, T., Brož, B., Osifová, Z., Dračínský, M., Mertlíková-Kaiserová, H., & Janeba, Z. (2024). Structure-Based Drug Design of ADRA2A Antagonists Derived from Yohimbine. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00323
Vancouver
Chayka A, Česnek M, Kužmová E, Kozák J, Tloušt'ová E, Dvořáková A, et al. Structure-Based Drug Design of ADRA2A Antagonists Derived from Yohimbine. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00323
BibTeX
@article{Chayka2024,
author = {Chayka, Artem and Česnek, Michal and Kužmová, Erika and Kozák, Jaroslav and Tloušt'ová, Eva and Dvořáková, Alexandra and Strmeň, Timotej and Brož, Břetislav and Osifová, Zuzana and Dračínský, Martin and Mertlíková-Kaiserová, Helena and Janeba, Zlatko},
title = {Structure-Based Drug Design of ADRA2A Antagonists Derived from Yohimbine},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00323}
}
EUVIMED